Gary Madsen, Ph.D.
CEO, ProTransit Nanotherapy
Gary Madsen, a native of Audubon, Iowa, was educated in Nebraska, receiving his bachelor’s degree from Dana College and then his master’s and PhD from Creighton University. From Creighton, Dr. Madsen was recruited to Abbott Laboratories in northern Illinois where he worked in diagnostics for 17 years. His primary roles were leadership positions in Hepatitis Aids, Allergy, automated systems and licensing/tech transfer. He was then recruited to IDEXX Laboratories in Westbrook, Maine as VP of R&D in the veterinarian diagnostics division. After IDEXX, Dr. Madsen joined a Madison, Wisconsin-based biotechnology company, EraGen Biosciences, as Chief Technical Officer. Dr. Madsen also has experience in product and business development in other biotech companies like Promega, Gilson and Third Wave. In 2012, Dr. Madsen was recruited as Entrepreneur-In-Residence for UNeMed, the technical transfer office of UNMC. Out of this role came the co-founding of ProTransit Nanotherapy, a drug delivery company, where he is President and CEO.